Latest News & Features
Americas
The US Food and Drug Administration’s Oncologic Drugs Advisory Committee has recommended approval of the first biosimilar version of trastuzumab, a breast cancer-fighting monoclonal antibody. 14 July 2017
Americas
Medical device company Alps South has filed a complaint against its former law firm Shumaker, Loop & Kendrick for legal malpractice. 14 July 2017
Big Pharma
The Federal Court of Justice, Germany’s Supreme Court, has upheld a lower court’s ruling that granted a preliminary compulsory licence to use a patent protecting an HIV treatment. 13 July 2017
Americas
A collaboration between Bill Gates and Intellectual Ventures , in partnership with conglomerate GE, has signed a licensing deal with US diagnostics technology company Access Bio to make and sell tools for “rapidly” identifying asymptomatic malaria. 13 July 2017
Big Pharma
The UK Supreme Court has reformulated the three questions that should be asked when testing for equivalent patent infringement. 12 July 2017
Big Pharma
The Italian Patent and Trademark Office’s Board of Appeal has ruled that there are no rules preventing the office from adjudicating requests to limit the term of supplementary protection certificates. 12 July 2017
Biotechnology
The European Patent Office has reopened cases in which the decision depends entirely on the patentability of plants or animals obtained by an essentially biological process. 11 July 2017
Americas
The Broad Institute of MIT and Harvard has announced that it has entered talks to create a worldwide licensing pool for CRISPR/Cas9 patents. 11 July 2017
Big Pharma
The UK Supreme Court has ruled that Actavis’s generic versions of cancer drug Alimta directly infringe patents owned by Eli Lilly, reversing two earlier decisions. 7 July 2017
Europe
Biotech company Silence Therapeutics has filed a case on supplementary protection certificates at the English Patents Court against Alnylam and The Medicines Company. 7 July 2017